首页> 外文期刊>Antiviral Research >Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A(961)V mutation in HHV-6 ganciclovir resistance.
【24h】

Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A(961)V mutation in HHV-6 ganciclovir resistance.

机译:人类疱疹病毒6 DNA聚合酶:酶参数,对更昔洛韦的敏感性以及A(961)V突变在HHV-6更昔洛韦耐药中的作用测定。

获取原文
获取原文并翻译 | 示例
       

摘要

Human herpesvirus 6 (HHV-6) is latent in the majority of the adult population. Due to its ability of causing opportunistic infections, alone or in concert with the other beta-herpesviruses human cytomegalovirus (HCMV) and HHV-7, its importance as a pathogen in immunocompromised patients has increasingly been recognized. We here report the characterization of the main antiviral target, the HHV-6 DNA polymerase, expressed in a eukaryotic in vitro transcription/translation assay. This technique represents a fast and straightforward approach for the study of existing and new inhibitors of HHV-6 DNA polymerase. The present study shows that ganciclovir is less active against HHV-6, as compared to its activity against HCMV, both in cell culture and at the enzymatic (i.e. DNA polymerase) level. Recently, a mutant HHV-6 strain carrying an amino acid substitution in the ganciclovir phosphorylating pU69 kinase has been isolated both from patients and in cell culture. The strain isolated in vitro, however, carriedan additional mutation in the viral DNA polymerase. From our experiments presented here, we conclude that the pU69 M(318)V amino acid substitution rather than the A(961)V substitution in HHV-6 DNA polymerase, is responsible for the ganciclovir-resistant phenotype.
机译:人类疱疹病毒6(HHV-6)在大多数成年人口中具有潜伏性。由于其单独或与其他β-疱疹病毒人巨细胞病毒(HCMV)和HHV-7一起引起机会感染的能力,人们日益认识到它作为免疫受损患者中病原体的重要性。我们在此报告了主要抗病毒靶标HHV-6 DNA聚合酶在真核生物体外转录/翻译测定中的表征。该技术代表了一种用于研究现有和新的HHV-6 DNA聚合酶抑制剂的快速而直接的方法。本研究表明,更昔洛韦在细胞培养和酶促(即DNA聚合酶)水平上均较其对HCMV的活性低,对HHV-6的活性较低。最近,已经从患者和细胞培养物中分离了在更昔洛韦磷酸化pU69激酶中带有氨基酸取代的突变型HHV-6菌株。然而,体外分离的菌株在病毒DNA聚合酶中携带另外的突变。从此处介绍的实验中,我们得出结论,在更HVHV-6 DNA聚合酶中,pU69 M(318)V氨基酸取代而不是A(961)V取代是更昔洛韦耐药性的表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号